title: The prevalence of haemochromatosis gene mutations in the West of Scotland and their relation to ischaemic heart disease.
abstract: OBJECTIVE
  Excess iron stores have been postulated to enhance the risk of ischaemic heart disease. This study aims to determine whether the two major mutations of the haemochromatosis (HFE) gene (C282Y and H63D) are associated with ischaemic heart disease (IHD) or myocardial infarction (MI).
  
  
  METHODS
  Cross sectional case-control study.
  
  
  METHODS
  The geographical area studied by the MONICA (monitoring trends and determinants in cardiovascular disease) heart attack register for North Glasgow in Scotland, UK.
  
  
  METHODS
  1009 control subjects chosen at random from general practitioner registers were studied. Additionally, 924 subjects who had survived a first MI sustained between 1985 and 1992 were identified from the MONICA register.
  
  
  METHODS
  C282Y and H63D mutations, previous MI, and presence or absence of IHD.
  
  
  RESULTS
  Mutant gene prevalences in the whole control population were as follows: C282Y: homozygote 0.9%, heterozygote 17.7%; H63D: homozygote 2.1%, heterozygote 25.5%; and compound heterozygote: 2.4%. Analysis by chi(2) test and logistic regression analysis did not identify any significant difference in genotype prevalence between normal control, IHD control, and MI survivor groups.
  
  
  CONCLUSIONS
  The C282Y homozygote and heterozygote prevalences are among the highest reported worldwide. No association between IHD or MI and HFE genotype was identified. However, these results need to be interpreted in the light of the cross sectional case-control nature of the study.
authors.affiliation: Department of Gastroenterology, Gartnavel General Hospital, Glasgow, UK.
authors.forename: S
authors.initials: S
authors.lastname: Campbell
authors.forename: D K
authors.initials: DK
authors.lastname: George
authors.forename: S D
authors.initials: SD
authors.lastname: Robb
authors.forename: R
authors.initials: R
authors.lastname: Spooner
authors.forename: T A
authors.initials: TA
authors.lastname: McDonagh
authors.forename: H J
authors.initials: HJ
authors.lastname: Dargie
authors.forename: P R
authors.initials: PR
authors.lastname: Mills
mesh_terms: D000368:Aged; D016022:Case-Control Studies; D003430:Cross-Sectional Studies; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006432:Hemochromatosis / Q000453:epidemiology / Q000235:genetics*; D000071020:Hemochromatosis Protein; D006579:Heterozygote; D015395:Histocompatibility Antigens Class I / Q000235:genetics*; D006720:Homozygote; D006801:Humans; D016015:Logistic Models; D008297:Male; D008565:Membrane Proteins / Q000235:genetics*; D009154:Mutation / Q000235:genetics*; D017202:Myocardial Ischemia / Q000453:epidemiology / Q000235:genetics*; D015995:Prevalence; D012044:Regression Analysis; D012606:Scotland / Q000453:epidemiology
chemical_list: C103673:HFE protein, human; D000071020:Hemochromatosis Protein; D015395:Histocompatibility Antigens Class I; D008565:Membrane Proteins